๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma

โœ Scribed by Tony S. K. Mok; Sarath Kanekal; Xiao Rong Lin; Thomas W. T. Leung; Anthony T. C. Chan; Winnie Yeo; Simon Yu; Karen Chak; Rich Leavitt; Philip Johnson

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
136 KB
Volume
91
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II study of flutamide in the treat
Phase II study of flutamide in the treatment of hepatocellular carcinoma
โœ Yee Chao; Wing-Kai Chan; Yi-Shin Huang; Ho-Chung Teng; Sun-Sang Wang; Wing-Yiu L ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 408 KB ๐Ÿ‘ 2 views

## BACKGROUND. Hepatocellular carcinoma (HCC) is a male predominant disease and may be an androgen-dependent or androgen-responsive tumor. This Phase I1 study was designed to investigate the clinical activity and toxicity of flutamide in the treatment of patients with advanced HCC. METHODS. Thirty

Intralesionally implanted cisplatin plus
Intralesionally implanted cisplatin plus systemic carmustine for the treatment of brain tumor in rats
โœ Kong, Qingzhong; Kleinschmidt-DeMasters, Bette K.; Lillehei, Kevin O. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 100 KB ๐Ÿ‘ 1 views

## Background and Objectives: The benefit of conventional chemotherapy for the treatment of malignant brain tumors, although limited, is real. A major obstacle in the treatment of these lesions is the ability to deliver drug across the blood-brain barrier (BBB). Local drug implantation, circumvent